Lantheus Holdings, Inc LNTH
Key Stats
- Today's Range
- $101.02 – $102.90
- 50-Day Range
- $93.57 – $111.86
- 52-Week Range
- $47.25 – $111.86
- Volume
- 8.24 million shs
- Average Volume
- 1.22 million shs
- Market Cap
- $6.59 billion
- P/E Ratio
- 24.44
- Dividend Yield
- —
Valuation
- P/E Ratio
- 24.44
- Price / Book
- 5.43
- Price / Sales
- 4.26
Short Interest
- Short Interest
- 0.72%
- Days to Cover
- 1.54
Financials (TTM)
- Revenue
- $1.55 billion
- Net Income
- $279.03 million
- Net Margin
- 18.05%
- Return on Equity
- 23.02%
- Debt-to-Equity
- —
About Lantheus Holdings, Inc
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.